• Contact Us
    • Contact Us
    • Adverse Event
  • Newsroom
    • Newsroom
    • Press Releases
    • Media Library
    • Corporate Press Kit
    • Product & Pipeline Media Resources
  • South Africa
    • Global
    • ArgentinaAustraliaAustriaBrazil
      CanadaENFR
      ChinaFrance
      GermanyItalyJapanMENANetherlandsNordic
      SingaporeSouth KoreaSpain
      SwitzerlandDEFRIT
      UKUnited States
  • Investors
    • NASDAQ
    • HKEX
    • SSE
  • Medical Information
BeOne Logo
  • About
    • About Us
    • Our Brand
    • Our Offices
  • Science
    • Research and Development
      • Research & Development Overview
      • Disease Focus Areas: Haematology
      • Disease Focus Areas: Solid Tumours
      • Pioneering Protein Degradation with CDACs
      • Antibody Drug Conjugates
    • Pipeline
    • Clinical Trials
      • Find a Trial
  • Patients
    • Our Commitment to Patients
    • Global Patient Safety
  • Responsibility
    • Operating Responsibly
      • Operating Responsibly Overview
      • Policies & Positions
      • Suppliers
      • Global Transparency
  • Careers
    • See Open Positions
  • Contact Us
    • Contact Us
    • Adverse Event
  • Newsroom
    • Newsroom
    • Press Releases
    • Media Library
    • Corporate Press Kit
    • Product & Pipeline Media Resources
  • South Africa
    • Global
    • ArgentinaAustraliaAustriaBrazil
      CanadaENFR
      ChinaFrance
      GermanyItalyJapanMENANetherlandsNordic
      SingaporeSouth KoreaSpain
      SwitzerlandDEFRIT
      UKUnited States
  • Investors
    • NASDAQ
    • HKEX
    • SSE
  • Medical Information

About our Brand Evolution – BeOne Medicines

We power global health

We know cancer has no borders.

So we help lead a global community united by a common goal. One that fuels our relentless innovation. Drives us to expand the scale of our reach, forges our commitment to getting critical medicine to patients everywhere. Quickly, efficiently, affordably. Together, we are how the world fights cancer. So the community can embrace the stories of heroes, patients, scientists, doctors, families. Everyone coming together to power global health.

 

“Be” represents the fundamental goal of any patient with cancer – simply to be.

The word “Onc” spelled in red within “One” illustrates our redoubled commitment to oncology

“One” emphasises our unity as a team and focus on bringing together patients, caregivers, scientists, healthcare providers, governments and industry with a shared mission to eliminate cancer together.

The power button within the last “e” represents our always “on” approach in pursuing novel medicines that turn cancer “off” by disrupting key drivers of cancer cell growth and survival, harnessing the body’s immune system to attack tumours, and targeting specific biomarkers of cancer. The tilted angle of the button embodies our path, which is not always straight-forward as we push the boundaries of science.

BeOne Logo

EXTERNAL LINKS

  • NASDAQ Investors
  • HKEX Investors
  • SSE Investors
  • Medical Information
  • Terms of Use
  • Privacy Policy

© BeOne Medicines I GmbH, 2025 All Rights Reserved.